КАРДІОЦИТОПРОТЕКЦІЯ – ОБ’ЄКТИВІЗОВАНІ МОЖЛИВОСТІ ПРИ КАРДІОВАСКУЛЯРНИХ ЗАХВОРЮВАННЯХ
DOI:
https://doi.org/10.24061/1727-4338.XX.4.78.2021.18Ключові слова:
L-аргінін, ендотеліальна дисфункція, ішемічна хвороба серця, серцева недостатністьАнотація
Мета роботи – об’єктивізація результатів опублікованих клінічних досліджень
впливу L-аргініну на перебіг кардіоваскулярних захворювань.
Висновки. Аналіз даних літератури підтверджує ефективність використання
L-аргініну при кардіоваскулярних захворюваннях, зокрема при артеріальній
гіпертензії, ішемічній хворобі серця, серцевій недостатності, захворюваннях
периферичних артерій. Корекція ендотеліальної дисфункції повинна бути рутинною
і обов'язковою частиною терапевтичних та профілактичних програм при лікуванні
пацієнтів із серцево-судинною патологією. Практикуючому лікарю необхідно
пам'ятати, що тільки стимулювати виснажений ендотелій малоефективно,
вкрай важливо надати субстрат, з якого ендотелій може синтезувати необхідні
речовини.
Посилання
Lopez MJ, Mohiuddin SS. Biochemistry, Essential Amino
Acids [Internet]. Treasure Island (FL): StatPearls Publishing;
[cited 2022 Jan 27]. 398 р. Available from: https://www.
ncbi.nlm.nih.gov/books/NBK557845/
Luiking YC, Ten Have GA, Wolfe RR, Deutz NEP. Arginine
de novo and nitric oxide production in disease states. Am
J Physiol Endocrinol Metab [Internet]. 2012[cited 2022
Jan 29];303(10):E1177-89. Available from: https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC3517635/ doi: 10.1152/
ajpendo.00284.2012
Agapie T, Suseno S, Woodward JJ, Stoll S, Britt, RD, Marletta
MA. NO formation by a catalytically self-sufficient bacterial
nitric oxide synthase from Sorangium cellulosum. Proc Natl Acad
Sci. 2009;106(38):16221-6. doi: 10.1073/pnas.0908443106
Andrew PJ, Mayer B. Enzymatic function of nitric oxide
synthases. Cardiovasc Res. 1999;43(3):521-31. doi: 10.1016/
s0008-6363(99)00115-7
Sax HC. Arginine stimulates wound healing and immune
function in elderly human beings. JPEN J Parenter Enteral Nutr.
;18(6):559-60. doi: 10.1177/0148607194018006559
O’Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH,
Kandel ER, et al. Endothelial NOS and the blockade of LTP
by NOS inhibitors in mice lacking neuronal NOS. Science.
;265(5171):542-6. doi: 10.1126/science.7518615
Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di
Silvio M, Wang SC, et al. Molecular cloning and expression of
inducible nitric oxide synthase from human hepatocytes. Proc
Natl Acad Sci. 1993;90(8):3491-5. doi: 10.1073/pnas.90.8.3491
Forstermann U, Sessa WC. Nitric oxide synthases: Regulation
and function. Eur Heart J. 2012;33(7):829-37. doi: 10.1093/
eurheartj/ehr304
Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases:
structure, function and inhibition. Biochem. J. 2001;357(Pt
:593-615. doi: 10.1042/0264-6021:3570593
Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di
Silvio M, Wang SC, et al. Molecular cloning and expression
of inducible nitric oxide synthase from human hepatocytes.
Proc Natl Acad Sci U S A. 1993;90(8):3491-5. doi: 10.1073/
pnas.90.8.3491
Nagarkoti S, Sadaf S, Awasthi D, Chandra T, Jagavelu K,
Kumar S, et al. L-Arginine and tetrahydrobiopterin supported
nitric oxide production is crucial for the microbicidal activity
of neutrophils. Free Radic Res. 2019;53(3):281-92. doi:
1080/10715762.2019.1566605
Stuehr DJ, Kwon NS, Nathan CF, Grith OW, Feldman PL,
Wiseman J. N omega-hydroxy-L-arginine is an intermediate in
the biosynthesis of nitric oxide from L-arginine. J Biol Chem.
;266(10):6259-63. doi: 10.1016/S0021-9258(18)38112-2
Haussinger D, Gerok W, Sies H. The effect of urea synthesis
on extracellular pH in isolated perfused rat liver. Biochem J.
;236(1):261-5. doi: 10.1042/bj2360261
Pandey D, Romer L, Berkowitz DE. Arginase II: Atherogenesis
beyond enzyme activity. J Am Heart Assoc [Internet]. 2013[cited
Jan 25];2(4):e000392. Available from: https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC3828780/pdf/jah3-2-e000392.
pdf doi: 10.1161/jaha.113.000392
Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG,
et al. Arginase inhibition restores NOS coupling and reverses
endothelial dysfunction and vascular stiffness in old rats. J
Appl Physiol (1985). 2009;107(4):1249-57. doi: 10.1152/
japplphysiol.91393.2008
Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling
and endothelial dysfunction in aged vessels. Am J Physiol
Heart Circ Physiol. 2009;297(5):1829-36. doi: 10.1152/
ajpheart.00230.2009
Gimbrone MA Jr, Garcia-Cardena G. Endothelial Cell
Dysfunction and the Pathobiology of Atherosclerosis. Circ Res.
;118(4):620-36. doi: 10.1161/circresaha.115.306301
Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R,
Santulli G. Is COVID-19 an Endothelial Disease? Clinical and
Basic Evidence. Preprints. 2020:2020040204. doi: 10.20944/
preprints202004.0204.v1
Sardu C, Gambardella J, Morelli MB, Wang X, Marfella
R, Santulli G. Hypertension, Thrombosis, Kidney Failure,
and Diabetes: Is COVID-19 an Endothelial Disease? A
Comprehensive Evaluation of Clinical and Basic Evidence.
J Clin Med [Internet]. 2020[cited 2022 Jan 29];9(5):1417.
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC7290769/pdf/jcm-09-01417.pdf doi: 10.3390/jcm9051417
Wang J, Saguner AM, An J, Ning Y, Yan Y, Li G. Dysfunctional
Coagulation in COVID-19: From Cell to Bedside. Adv Ther.
;37(7):3033-9. doi: 10.1007/s12325-020-01399-7
Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric Oxide
and Endothelial Dysfunction. Crit Care Clin. 2020;36(2):307-
doi: 10.1016/j.ccc.2019.12.009
Alvares TS, Conte-Junior CA, Silva JT, Paschoalin VMF.
Acute L-Arginine supplementation does not increase nitric
oxide production in healthy subjects. Nutr Metab [Internet].
[cited 2022 Jan 27];9(1):54. Available from: https://www.
ncbi.nlm.nih.gov/pmc/articles/PMC3489573/pdf/1743-7075-9-
pdf doi: 10.1186/1743-7075-9-54
Schwedhelm R, Maas R, Freese R, Jung D, Lukacs Z,
Jambrecina A, et al. Pharmacokinetic and pharmacodynamic
properties of oral L-citrulline and L-arginine: Impact on nitric
oxide metabolism. Br J Clin Pharmacol. 2008;65(1):51-9. doi:
1111/j.1365-2125.2007.02990.x
Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a
calmodulin-requiring enzyme. Proc Natl.Acad.Sci. U S A.
;87(2):682-5. doi: 10.1073/pnas.87.2.682
Joyner MJ, Casey DP. Regulation of increased blood flow
(hyperemia) to muscles during exercise: A hierarchy of
competing physiological needs. Physiol Rev. 2015;95(2):549-
doi: 10.1152/physrev.00035.2013
Alvares TS, Meirelles CM, Bhambhani YN, Paschoalin
VMF, Gomes PSC. L-Arginine as a potential ergogenic aid
in healthy subjects. Sports Med. 2011;41(3):233-48. doi:
2165/11538590-000000000-00000
Dioguardi FS. To give or not to give? Lessons from the arginine
paradox. J Nutrigenet Nutrigenomics. 2011;4(2):90-8. doi:
1159/000327777
Bartnicki P, Kowalczyk M, Franczyk-Skora B, Baj Z, Rysz
J. Evaluation of Endothelial (dys)Function, Left Ventricular
Structure and Function in Patients with Chronic Kidney Disease.
Curr Vasc Pharmacol. 2016;14(4):360-7. doi: 10.2174/1570161
Strobel J, Muller Zolk O, Endress B, Konig J, Fromm MF, et al.
Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2
(OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Amino Acids. 2013;45(4):989-1002. doi: 10.1007/s00726-013-
-3
Wijnands KA, Hoeksema MA, Meesters DM, van den Akker
NM, Molin DG, Briede JJ, et al. Arginase-1 deficiency regulates
arginine concentrations and NOS2-mediated NO production
during endotoxemia. PLoS ONE [Internet]. 2014[cited 2022
Jan 25];9(1):e86135. Available from: https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC3897658/pdf/pone.0086135.pdf doi:
1371/journal.pone.0086135
Abedini S, Meinitzer A, Holme I, Marz W, Weihrauch G,
Fellstrom B, et al. Asymmetrical dimethylarginine is associated
with renal and cardiovascular outcomes and all-cause mortality
in renal transplant recipients. Kidney Int. 2010;77(1):44-50. doi:
1038/ki.2009.382
Sundar UM, Ugusman A, Chua HK, Latip J, Aminuddin
A. Piper sarmentosum Promotes Endothelial Nitric Oxide
Production by Reducing Asymmetric Dimethylarginine in
Tumor Necrosis Factor-α-Induced Human Umbilical Vein
Endothelial Cells. Front Pharmacol [Internet]. 2019[cited 2022
Jan 29];10:1033. Available from: https://www.ncbi.nlm.nih.
gov/pmc/articles/PMC6758593/pdf/fphar-10-01033.pdf doi:
3389/fphar.2019.01033
Notsu Y, Yano S, Shibata H, Nagai A, Nabika T. Plasma arginine/
ADMA ratio as a sensitive risk marker for atherosclerosis:
Shimane CoHRE study. Atherosclerosis. 2015;239(1):61-6. doi:
1016/j.atherosclerosis.2014.12.030
Notsu Y, Nabika T, Bokura H, Suyama Y, Kobayashi S,
Yamaguchi S, et al. Evaluation of asymmetric dimethylarginine
and homocysteine in microangiopathy-related cerebral damage.
Am J Hypertens. 2009;22(3):257-62. doi: 10.1038/ajh.2008.346
Santulli G. MicroRNAs Distinctively Regulate Vascular
Smooth Muscle and Endothelial Cells: Functional Implications
in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.
Adv Exp Med Biol. 2015;887:53–77. doi: 10.1007/978-3-319-
-3_4
Ogita H, Liao J. Endothelial function and oxidative
stress. Endothelium. 2004;11(2):123-32. doi:
1080/10623320490482664
Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L,
Cozzolino D, et al. The vascular effects of L-Arginine in humans.
The role of endogenous insulin. J Clin Investig. 1997;99(3):433-
doi: 10.1172/JCI119177
Gates PE, Boucher ML, Silver AE, Monahan KD, Seals D.R.
Impaired flow-mediated dilation with age is not explained
by L-arginine bioavailability or endothelial asymmetric
dimethylarginine protein expression. J Appl Physiol.
;102(1):63-71. doi: 10.1152/japplphysiol.00660.2006
Bode-Boger SM, Muke J, Surdacki A, Brabant G, Boger RH,
Frolich JC. Oral L-arginine improves endothelial function in
healthy individuals older than 70 years. Vasc Med. 2003;8(2):77-
doi: 10.1191/1358863x03vm474oa
Blum A, Miller H, Blum A, Miller H. The efects of L-arginine
on atherosclerosis and heart disease. Int J Cardiovasc Intervent.
;2(2):97-100. doi: 10.1080/acc.2.2.97.100
Adams MR, McCredie R, Jessup W, Robinson J, Sullivan
D, Celermajer DS. Oral L-arginine improves endotheliumdependent dilatation and reduces monocyte adhesion to
endothelial cells in young men with coronary artery disease.
Atherosclerosis. 1997;129(2):261-9. doi: 10.1016/s0021-
(96)06044-3
Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Efect of
supplemental oral L-arginine on exercise capacity in patients
with stable angina pectoris. Am J Cardiol. 1997;80(3):331-3.
doi: 10.1016/s0002-9149(97)00354-8
Yin WH, Chen JW, Tsai C, Chiang, MC, Young, MS, Lin SJ.
L-arginine improves endothelial function and reduces LDL
oxidation in patients with stable coronary artery disease. Clin
Nutr. 2005;24(6):988-97. doi: 10.1016/j.clnu.2005.07.003
Walker HA, McGing E, Fisher I, Boger RH, Bode-Boger
SM, Jackson G, et al. Endothelium-dependent vasodilation
is independent of the plasma L-arginine/ADMA ratio in
men with stable angina: Lack of efect of oral L-arginine on
endothelial function, oxidative stress and exercise performance.
J Am Coll Cardiol. 2001;38(2):499-505. doi: 10.1016/S0735-
(01)01380-8
Padilla F, Garcia-Dorado D, Agullo L, Inserte J, Paniagua A,
Mirabet S, et al. L-Arginine administration prevents reperfusioninduced cardiomyocyte hypercontracture and reduces infarct
size in the pig. Cardiovasc Res. 2000;46(3):412-20. doi:
1016/S0008-6363(00)00048-1
Parnell MM, Holst DP, Kaye DM. Augmentation of endothelial
function following exercise training is associated with
increased L-arginine transport in human heart failure. Clin Sci.
;109(6):523-30. doi: 10.1042/cs20050171
Maxwell AJ, Cooke JP. Cardiovascular effects of L-arginine.
Curr Opin Nephrol Hypertens. 1998;7(1):63-70. doi:
1097/00041552-199801000-00011
Maxwell AJ, Anderson BE, Cooke JP. Nutritional therapy for
peripheral arterial disease: A double-blind, placebo-controlled,
randomized trial of HeartBar. Vasc Med. 2000;5(1):11-9.
doi: 10.1177/1358836x0000500103
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2022 В.К. Тащук, Г.І. Хребтій, Т.С. Вовчок, М.О. Вінтоняк, В.В. Анфілофієва
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Часопис користується «Типовим шаблоном положення про авторські права».
